- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens unveils enhancements to Axiom Sireskop SD
Siemens Medical Solutions has introduced at the RSNA meeting a digital enhancement and mobile flat-panel detector for its Axiom Sireskop SD. With the addition of those upgrades, all Siemens AX systems are now available in a digital format.
Siemens Medical Solutions has introduced at the RSNA meeting a digital enhancement and mobile flat-panel detector for its Axiom Sireskop SD. With the addition of those upgrades, all Siemens AX systems are now available in a digital format.
"We are helping our customers reach their goals of improving workflow and patient throughput, and more important, patient care," said Manfred Fink, vice president of the Siemens angiography and x-ray division.
The Sireskop SD is a universal system designed to streamline fluoroscopy and radiography operations, as well as patient flow, during fluoroscopic and radiographic procedures. It gives medical professionals a single imaging system for procedures ranging from pediatrics to bariatrics.
The enhancement will enable facilities to improve workflow by decreasing the steps required to process images without film or cassettes, Fink said. Additionally, the system provides an integrated workstation that allows technologists to focus more on the patient during postprocessing.
The tableside-controlled system includes comprehensive dose reduction and high-capacity x-ray tubes to provide flexibility for various patient types without sacrificing image quality. The Sireskop SD also has a wide table and high weight limit to accommodate heavier patients. It meets the performance standards common to other Axiom products, such as enhanced workflow and efficiency, optimal image quality, reduced radiation dose, and patient comfort.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
